Wednesday broker round-up
18th Mar 2020 13:42
(Sharecast News) - Polypipe: Deutsche Bank upgrades to buy with a target price of 550p.
Read moreWednesday broker round-up
11th Mar 2020 13:37
(Sharecast News) - Clinigen Group: Liberum upgrades to buy with a target price of 780.0p.
Read moreTuesday broker round-up
25th Feb 2020 13:15
(Sharecast News) - Redrow: Jefferies upgrades to buy with a target price of 981p.
Read moreClinigen sees FY revenues and profits improving
16th Jan 2020 11:02
(Sharecast News) - Pharmaceutical company Clinigen expects full-year revenues and gross profits to have improved during its recently wrapped up trading year.
Read moreMonday broker round-up
16th Dec 2019 13:18
(Sharecast News) - Tullow Oil: HSBC downgrades to reduce with a target price of 50p.
Read moreTuesday broker round-up
15th Oct 2019 12:47
(Sharecast News) - Ocado: JP Morgan downgrades to underweight with a target price of 1,050p.
Read moreThursday broker round-up
19th Sep 2019 13:29
(Sharecast News) - Ferguson: RBC Capital Markets downgrades to underperform with a target price of 5,100p.
Read moreClinigen to take back US rights to cancer drugs
15th May 2019 12:43
(Sharecast News) - Aim's Clinigen Group is taking back control of two oncology drugs from US partner Cumberland Pharmaceuticals.
Read moreClinigen monopolises global rights for skin cancer treatment
2nd Apr 2019 10:57
(Sharecast News) - Clinigen now owns the global rights to Proleukin after having acquired the US rights to the treatment on Tuesday following US anti-trust clearance.
Read moreClinigen earnings grow following CSM and iQone acquisitions
27th Feb 2019 10:23
(Sharecast News) - Specialty pharmaceuticals group Clinigen saw strong earnings and cash flow growth in the first half of its trading year following a period of transformative acquisitions.
Read moreWednesday broker round-up
20th Feb 2019 13:19
(Sharecast News) - Ocado: Peel Hunt downgrades to hold with a target price of 110p.
Read moreWednesday broker round-up
13th Feb 2019 12:50
(Sharecast News) - Workspace Group: Berenberg downgrades to hold with a target price of 900p.
Read moreClinigen bounds upwards on purchase of Proleukin's US rights
13th Feb 2019 10:05
(Sharecast News) - Clinigen Group shares jumped on Wednesday after the company signed an agreement with Novartis to acquire the US rights to its Proleukin drug for up to $210m in cash.
Read moreClinigen appoints Nick Keher as new CFO
5th Feb 2019 07:56
(Sharecast News) - AIM-listed pharmaceutical and services company Clinigen Group has appointed Nick Keher as its new chief financial officer with effect from 19 March.
Read moreAcquisitions spur Clinigen to profit and revenue growth
15th Jan 2019 09:22
(Sharecast News) - Clinigen Group on Tuesday reported that, following a series of acquisitions, it expects to report a sharp rise in revenue and profit when it publishes its half-year results next month.
Read more